Search Results: immunotherapy

• Health & Medicine
• Science & Technology

News digest – junk food ad ban, cancer-killing viruses, immunotherapy on the NHS and sugar supplements

In the news this week: more NHS patients will receive immunotherapy and we explain why a sugar supplement isn’t a proven cancer treatment just yet. In the news this week: more NHS patients will receive immunotherapy and we explain why a sugar supplement isn’t a proven cancer treatment just yet.

24 November 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with lung cancer

Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England. Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England.

22 November 2018

• Health & Medicine

Immunotherapy drug to be made available for some NHS patients with advanced skin cancer

Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England. Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England.

21 November 2018

• Science & Technology
• Health & Medicine

News digest – breast cancer trials, height and cancer risk, bowel cancer in young people and immunotherapy

In the news this week: promising clinical trial results from ESMO 2018 and we call out an anti-smoking campaign’s hypocrisy. In the news this week: promising clinical trial results from ESMO 2018 and we call out an anti-smoking campaign’s hypocrisy.

27 October 2018

• Health & Medicine

Immunotherapy trial shows promise for some women with an aggressive breast cancer

An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer. An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer.

23 October 2018

• Science & Technology
• Health & Medicine

News digest – Nobel Prize winners, personalised immunotherapy on NHS, Australian cervical cancer rates and Theresa May’s cancer plans

In the news this week: Nobel Prize for Medicine awarded to scientists who laid the groundwork for cancer immunotherapy. In the news this week: Nobel Prize for Medicine awarded to scientists who laid the groundwork for cancer immunotherapy.

6 October 2018

• Health & Medicine

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments. With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

5 October 2018

• Science & Technology
• Health & Medicine

News digest – NHS to fund personalised immunotherapy, bowel cancer screening, worldwide inactivity and living with a brain tumour

In the news this week: NHS will fund personalised cell therapy for some children with blood cancer and bowel cancer screening uptake is dropping. In the news this week: NHS will fund personalised cell therapy for some children with blood cancer and bowel cancer screening uptake is dropping.

8 September 2018

• Health & Medicine

NHS England to fund personalised blood cancer immunotherapy

A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.

5 September 2018

• Science & Technology
• Health & Medicine

News digest – blood cancer immunotherapy, energy drink ban, ‘no-deal’ Brexit plans and our Annual Review

In the news this week: engineered cell therapy given initial ‘no’ for NHS in England and we publish our research highlights in our 2017/18 annual review. In the news this week: engineered cell therapy given initial ‘no’ for NHS in England and we publish our research highlights in our 2017/18 annual review.

1 September 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with Hodgkin lymphoma

The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England. The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England.

27 July 2018

• Science & Technology
• Health & Medicine

News digest – immunotherapy for childhood cancer, glowing brain surgery, a new health secretary and CRISPR

A dye used in brain tumour surgery will be rolled out more widely and an immunotherapy drug for neuroblastoma has been made available on NHS. A dye used in brain tumour surgery will be rolled out more widely and an immunotherapy drug for neuroblastoma has been made available on NHS.

14 July 2018